These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Identification of patients with high-risk for pulmonary metastases after curative resection of colorectal cancer. Anannamcharoen S; Boonya-Ussadol C J Med Assoc Thai; 2012 May; 95 Suppl 5():S86-91. PubMed ID: 22934451 [TBL] [Abstract][Full Text] [Related]
25. Identification of immunohistochemical prognostic markers for survival after resection of pulmonary metastases from colorectal carcinoma. Pfannschmidt J; Bade S; Hoheisel J; Muley T; Dienemann H; Herpel E Thorac Cardiovasc Surg; 2009 Oct; 57(7):403-8. PubMed ID: 19795327 [TBL] [Abstract][Full Text] [Related]
26. Surgical resection of pulmonary metastases from colorectal carcinoma. Five-year survival and main prognostic factors. Baron O; Amini M; Duveau D; Despins P; Sagan CA; Michaud JL Eur J Cardiothorac Surg; 1996; 10(5):347-51. PubMed ID: 8737691 [TBL] [Abstract][Full Text] [Related]
27. Serum carcinoembryonic antigen monitoring after curative resection for colorectal cancer: clinical significance of the preoperative level. Park IJ; Choi GS; Lim KH; Kang BM; Jun SH Ann Surg Oncol; 2009 Nov; 16(11):3087-93. PubMed ID: 19629600 [TBL] [Abstract][Full Text] [Related]
28. Is carcino-embryonic antigen useful in the follow-up management of patients with colorectal liver metastases? Bakalakos EA; Burak WE; Young DC; Martin EW Am J Surg; 1999 Jan; 177(1):2-6. PubMed ID: 10037299 [TBL] [Abstract][Full Text] [Related]
29. [Prognostic factors affecting the surgical treatment of metastatic lung tumor from colorectal cancer]. Otani Y; Shomura H; Aiyama T; Funai T; Tsuji T; Orimo T; Shonaka T; Shibaki T; Yanagida N; Inagaki M; Akabane H; Nakano S Kyobu Geka; 2013 Apr; 66(4):279-83. PubMed ID: 23575178 [TBL] [Abstract][Full Text] [Related]
36. Outcome of surgical resection for recurrent pulmonary metastasis from colorectal carcinoma. Kanzaki R; Higashiyama M; Oda K; Fujiwara A; Tokunaga T; Maeda J; Okami J; Tanaka K; Shingai T; Noura S; Ohue M; Kodama K Am J Surg; 2011 Oct; 202(4):419-26. PubMed ID: 21824604 [TBL] [Abstract][Full Text] [Related]
37. Long-term outcomes after surgical resection of pulmonary metastases from colorectal cancer. Suzuki H; Kiyoshima M; Kitahara M; Asato Y; Amemiya R Ann Thorac Surg; 2015 Feb; 99(2):435-40. PubMed ID: 25499475 [TBL] [Abstract][Full Text] [Related]
38. Post-chemotherapeutic CEA and CA19-9 are prognostic factors in patients with colorectal liver metastases treated with hepatic resection after oxaliplatin-based chemotherapy. Sakamoto Y; Miyamoto Y; Beppu T; Nitta H; Imai K; Hayashi H; Baba Y; Yoshida N; Chikamoto A; Baba H Anticancer Res; 2015 Apr; 35(4):2359-68. PubMed ID: 25862901 [TBL] [Abstract][Full Text] [Related]
39. Vascular endothelial growth factor expression in metastatic pulmonary tumor from colorectal carcinoma: utility as a prognostic factor. Tamura M; Oda M; Tsunezuka Y; Matsumoto I; Kawakami K; Watanabe G J Thorac Cardiovasc Surg; 2004 Oct; 128(4):517-22. PubMed ID: 15457151 [TBL] [Abstract][Full Text] [Related]
40. Pre- and postoperative carcinoembryonic antigen determinations in hepatic resection for colorectal metastases. Predictive value and implications for adjuvant treatment based on multivariate analysis. Hohenberger P; Schlag PM; Gerneth T; Herfarth C Ann Surg; 1994 Feb; 219(2):135-43. PubMed ID: 8129484 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]